Document Details
Form
Filing Date
Feb 24, 2022
Document Date
Feb 22, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Xeris Biopharma Holdings, Inc.
Issuer
XERIS BIOPHARMA HOLDINGS, INC.
Filer
PRESTRELSKI STEVEN